These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1736607)

  • 1. Identification of patients at high risk for recurrence of sustained ventricular tachycardia after healing of acute myocardial infarction.
    Rodriguez LM; Oyarzun R; Smeets J; Brachmann J; Schmitt C; Brugada P; Geelen P; Lipcsei G; Albert A; Wellens HJ
    Am J Cardiol; 1992 Feb; 69(5):462-4. PubMed ID: 1736607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and timing of recurrences of sudden death and ventricular tachycardia during antiarrhythmic drug treatment after myocardial infarction.
    Rodriguez LM; Smeets J; O'Hara GE; Geelen P; Brugada P; Wellens HJ
    Am J Cardiol; 1992 Jun; 69(17):1403-6. PubMed ID: 1590227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in inducibility of sustained ventricular tachycardia from two to twenty weeks after acute myocardial infarction.
    Bhandari AK; Au PK; Rose JS; Kotlewski A; Blue S; Rahimtoola SH
    Am J Cardiol; 1987 Feb; 59(4):284-90. PubMed ID: 3812277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of sustained ventricular arrhythmias presenting within eight weeks of acute myocardial infarction.
    Kron IL; Lerman B; DiMarco JP
    Ann Thorac Surg; 1986 Jul; 42(1):13-6. PubMed ID: 3729611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial).
    Mehta RH; Yu J; Piccini JP; Tcheng JE; Farkouh ME; Reiffel J; Fahy M; Mehran R; Stone GW
    Am J Cardiol; 2012 Mar; 109(6):805-12. PubMed ID: 22196782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk stratification and prognosis of patients treated with amiodarone for malignant ventricular tachyarrhythmias after myocardial infarction.
    Proclemer A; Facchin D; Vanuzzo D; Feruglio GA
    Cardiovasc Drugs Ther; 1993 Aug; 7(4):683-9. PubMed ID: 8241012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Gibson CM; Pride YB; Buros JL; Lord E; Shui A; Murphy SA; Pinto DS; Zimetbaum PJ; Sabatine MS; Cannon CP; Josephson ME;
    J Am Coll Cardiol; 2008 Feb; 51(5):546-51. PubMed ID: 18237683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of postmyocardial infarction patients with ventricular tachycardia or ventricular fibrillation treated with amiodarone.
    Strasberg B; Kusniec J; Zlotikamien B; Mager A; Sclarovsky S
    Am J Cardiol; 1990 Sep; 66(7):673-8. PubMed ID: 2399883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and prognosis of ventricular tachycardia/ventricular fibrillation in patients with post-infarction left ventricular aneurysm: Analysis of 575 cases.
    Ning X; Ye X; Si Y; Yang Z; Zhao Y; Sun Q; Chen R; Tang M; Chen K; Zhang X; Zhang S
    J Electrocardiol; 2018; 51(4):742-746. PubMed ID: 29803411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (the MILIS Study). Multicenter Investigation of the Limitation of Infarct Size.
    Tofler GH; Stone PH; Muller JE; Rutherford JD; Willich SN; Gustafson NF; Poole WK; Sobel BE; Willerson JT; Robertson T
    Am J Cardiol; 1987 Oct; 60(10):755-61. PubMed ID: 3661389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dispersions of the QT interval in postmyocardial infarction patients presenting with ventricular tachycardia or with ventricular fibrillation.
    Oikarinen L; Viitasalo M; Toivonen L
    Am J Cardiol; 1998 Mar; 81(6):694-7. PubMed ID: 9527076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and significance of induced sustained ventricular tachycardia or fibrillation two weeks after acute myocardial infarction.
    Bhandari AK; Rose JS; Kotlewski A; Rahimtoola SH; Wu D
    Am J Cardiol; 1985 Nov; 56(12):737-42. PubMed ID: 4061296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, Predictors, and Outcome Associated With Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction.
    Hanada K; Kinjo T; Yokoyama H; Tsushima M; Senoo M; Ichikawa H; Nishizaki F; Shibutani S; Yokota T; Okumura K; Tomita H
    Circ J; 2024 Jul; 88(8):1254-1264. PubMed ID: 37766557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the induction of ventricular flutter or fibrillation at electrophysiologic testing after myocardial infarction have any prognostic significance?
    Bourke JP; Richards DA; Ross DL; McGuire MA; Uther JB
    Am J Cardiol; 1995 Mar; 75(7):431-5. PubMed ID: 7863984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new risk score for ventricular tachyarrhythmia in acute myocardial infarction with preserved left ventricular ejection fraction.
    Lee SH; Jeong MH; Kim JH; Kim MC; Sim DS; Hong YJ; Ahn Y; Chae SC; Seong IW; Park JS; Chae JK; Hur SH; Cha KS; Kim HS; Gwon HC; Seung KB; Rha SW;
    J Cardiol; 2018 Nov; 72(5):420-426. PubMed ID: 29779893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
    Kuchar DL; Garan H; Venditti FJ; Finkelstein D; Rottman JN; McComb J; McGovern BA; Ruskin JN
    Am J Cardiol; 1989 Jul; 64(1):33-6. PubMed ID: 2741811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.
    Mehta RH; Starr AZ; Lopes RD; Hochman JS; Widimsky P; Pieper KS; Armstrong PW; Granger CB;
    JAMA; 2009 May; 301(17):1779-89. PubMed ID: 19417195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Ventricular Tachycardia or Fibrillation in Patients With ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention and Impact on Mortality and Stent Thrombosis (from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial).
    Kosmidou I; Embacher M; McAndrew T; Dizon JM; Mehran R; Ben-Yehuda O; Mintz GS; Stone GW
    Am J Cardiol; 2017 Nov; 120(10):1755-1760. PubMed ID: 28867126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.